Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.
about
Rethinking the immune properties of bilirubin in viral hepatitis: from bench to bedsideHeat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseasesThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cellsBiliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.Heme oxygenase effect on mesenchymal stem cells action on experimental Alzheimer's disease.Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunitiesThe neuropathological profile of mild cognitive impairment (MCI): a systematic review.Go green: the anti-inflammatory effects of biliverdin reductase.Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.Milk Intake at Midlife and Cognitive Decline over 20 Years. The Atherosclerosis Risk in Communities (ARIC) Study.Fe-oxy adducts of heme-Aβ and heme-hIAPP complexes: intermediates in ROS generation.Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.Cytochrome c peroxidase activity of heme bound amyloid β peptides.Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins
P2860
Q26771481-1EF2C4D2-FC04-43BC-BB12-DAFDA89B322BQ26778791-B55B9896-3E12-408D-A02F-8679717AF312Q26823454-148F46D2-EC75-4C5E-B20E-896FE23E0567Q26827320-82AD21E7-4CA2-4A4C-8DE6-D9CD48F1DF7FQ30367032-DAC0357E-E5E0-456D-8DD9-9A029C6CF86BQ33608918-5BEA0EB6-6C27-45D4-A4F0-F22C8E9D75A1Q33737263-8E3141DF-25AD-4793-8BA6-6D25565E9F6AQ33860500-EDBFC1FF-5991-415F-85B3-334E5FA9159FQ34014666-95F25772-8CB2-407C-89F2-615A4EBBC872Q34094516-E7B0006C-2861-4CA1-AF21-8EEA7AFF0013Q35059268-F7A066C9-D07B-47B3-A6A9-8343E25B4B01Q36041047-F6ABDDE9-ACF6-4597-932E-5E1BEF3FE933Q36330120-3D058C40-19C7-4925-B3B1-DC2833CC34EDQ36367840-8B065433-342C-4B29-8F21-3C3838FFAEFCQ37111515-D0C3BC77-2ADB-4E79-8A32-468B2102694CQ37605018-F2AB9FBF-70C4-45EF-B52E-00FAA9907C54Q37964897-676A4B07-CA26-4259-8F83-56041E96A9D8Q37996018-9A393FF9-0591-43BB-B45B-01500F49DBFFQ38162657-143DB5E4-95E2-459C-BAA1-4DA2049C191CQ46102290-6A097A55-8E52-4969-B1F7-196A1EA5A41DQ46460032-1C565900-BFF8-4656-B258-90C26584E29FQ48833283-602E027A-19E1-4790-91C7-C428A4ACABABQ49036734-F595AF7E-B989-4CF2-99F1-8A62AAA07DA5Q51716333-78E6439A-7782-4823-8F9C-CD708020EFBDQ57983933-3068AF0C-EA3B-4085-9D43-26E9A8C2D718
P2860
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@ast
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@en
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@nl
type
label
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@ast
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@en
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@nl
prefLabel
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@ast
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@en
Biliverdin reductase--a protei ...... and mild cognitive impairment.
@nl
P2093
P2860
P50
P1476
Biliverdin reductase--a protei ...... and mild cognitive impairment
@en
P2093
D Allan Butterfield
Marzia Perluigi
Paolo Preziosi
Rukhsana Sultana
P2860
P304
P356
10.1016/J.BBADIS.2011.01.005
P407
P577
2011-01-15T00:00:00Z